The mission of this team is to support the company by functioning as the internal expert in rare hematologic conditions - focusing on recent launch in Immune Thrombocytopenia (ITP), and potentially including warm Autoimmune Hemolytic Anemia (wAIHA), and Sickle Cell Disease (SCD) among other rare blood disorders - and helping Health Care Professionals and Payers optimize patient care and treatment outcomes through evidence-based decisions. The Senior Medical Director will establish and maintain collaborative medical and scientific relationships with key external physicians and internal constituencies from multiple functional groups - including, but not limited to, Medical Affairs, Clinical Research, Regulatory, Science, Marketing, Sales, Commercial Operations, and Patient and Product Services - while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements.